Atherosclerotic cardiovascular diseases (ASCVD) are the leading cause of death worldwide.
High levels of total cholesterol—and of low-density lipoprotein cholesterol in particular—are …

Objective Statins have been shown to be beneficial for the prevention of cardiovascular
events. In elderly individuals, the efficacy of statins remains controversial and the …

Objectives The benefits of initiating statins in the elderly remains debated. We evaluated the
effects of initiating statins in the elderly, according to cardiovascular risk. Methods This …

Owing to the progressive aging of the population, and the fact that cardiovascular disease
(CVD) is the leading cause of death among the elderly, the prevention of CVD in the elderly …

Background Current evidence from randomized controlled trials on statins for primary
prevention of cardiovascular disease (CVD) in older people, especially those aged> 75 …

The elderly represent a notable proportion of patients who present with myocardial infarction
or acute coronary syndromes. This subgroup of patients also experiences a higher …

Abstract Purpose of Review Hypercholesterolemia and statin treatment are nowadays
common among people older than 75 years, but clinical heterogeneity in this increasing age …

Background Population aging is a global trend, and the elderly have a higher risk of
atherosclerotic cardiovascular disease (ASCVD) and related mortality. Statins have been …

Cardiovascular disease (CVD) is the leading cause of death, with a higher prevalence in
older adults who form an increasing proportion of the population of the United States. Statin …

Australia's oldest old are potentially being harmed by the under-and over-use of statins.
Variations in prescription of statins are in part due to the vacuum of clinical research trial …